NPM3

NPM3 is a nuclear histone chaperone that functions largely through partnership with NPM1/B23 to regulate ribosome biogenesis and chromatin remodeling (PMID:15596447, PMID:22362753). It binds B23/NPM1 directly via the B23 N-terminus in an RNase- and salt-resistant manner, localizes to the nucleolus in an rRNA-transcription-dependent fashion, and the NPM3–B23 complex represses pre-rRNA synthesis and processing (PMID:15596447). On its own NPM3 has minimal nucleosome assembly and sperm chromatin decondensation activity; oligomerization with NPM1 is required to elicit these chaperone activities, and NPM3 reciprocally suppresses the RNA-binding activity of NPM1 to enhance NPM1 nucleoplasm-to-nucleolus shuttling (PMID:22362753). During spermiogenesis NPM3 interacts with transition protein TP2, an interaction blocked by p300/KAT3B-mediated acetylation of TP2, coupling NPM3 chaperone function to spermatid chromatin remodeling (PMID:19710011). In gastric cancer NPM3 mRNA is stabilized by PUM1, and NPM3 promotes NPM1 nuclear translocation to drive PD-L1 transcription and immune escape (PMID:38029539). A separate report assigns NPM3 a lactyltransferase activity catalyzing histone H3K18 and H3K27 lactylation to activate FASN transcription and necroptosis in diabetic cardiomyopathy (PMID:41803151).

1. 2001 Medium

   Established the basic subcellular distribution of human NPM3, the first step in placing it in a functional compartment.

   Evidence Subcellular fractionation of epitope-tagged NPM3 in NIH3T3 cells

   PMID:11722795

   Open questions at the time

   • Single method, single cell line
   • Does not resolve nucleolar versus nucleoplasmic localization or condition-dependence
2. 2004 High

   Answered how NPM3 acts in the nucleus by showing it binds B23/NPM1 and the complex represses ribosome biogenesis, defining its first molecular function and partner.

   Evidence Yeast two-hybrid, reciprocal Co-IP, deletion mapping, rRNA-dependent nucleolar imaging, and pre-rRNA pulse-labeling in overexpressing cells

   PMID:15596447

   Open questions at the time

   • Mechanism by which the complex inhibits pre-rRNA synthesis not resolved
   • Stoichiometry and structure of the NPM3–B23 complex not defined
3. 2009 Medium

   Linked NPM3 chaperone activity to a developmental program by identifying its interaction with TP2 and showing acetylation regulates the interaction.

   Evidence Co-IP of TP2 and NPM3, in vitro p300 acetylation with MS site mapping, and CD/AFM DNA condensation assays

   PMID:19710011

   Open questions at the time

   • In vivo requirement during spermiogenesis not established
   • Functional consequence of disrupting the TP2–NPM3 interaction for chromatin not directly tested in vivo
4. 2012 High

   Resolved the activity dependency by demonstrating NPM3 requires NPM1 oligomerization for nucleosome assembly/decondensation while reciprocally tuning NPM1 RNA binding and shuttling.

   Evidence Reconstituted in vitro chromatin decondensation and nucleosome assembly assays with recombinant NPM proteins, Co-IP, RNA-binding assays, and live-cell NPM1 shuttling imaging

   PMID:22362753

   Open questions at the time

   • Structural basis of NPM3–NPM1 heterooligomerization not defined
   • Cellular contexts where NPM3 modulates NPM1 shuttling not enumerated
5. 2023 Medium

   Extended NPM3 into a disease pathway by showing PUM1-mediated mRNA stabilization drives NPM3-dependent NPM1 nuclear translocation and PD-L1-mediated immune escape in gastric cancer.

   Evidence RIP, RNA stability assay, Co-IP, ChIP at the PD-L1 promoter, and T-cell killing assays with knockdown/overexpression in vitro and in vivo

   PMID:38029539

   Open questions at the time

   • Direct mechanism by which NPM3 promotes NPM1 nuclear translocation not defined
   • Single tumor type and single lab
6. 2026 Medium

   Proposed an entirely new enzymatic identity for NPM3 as a histone lactyltransferase driving FASN transcription and necroptosis in diabetic cardiomyopathy.

   Evidence DCM mouse model with NPM3 knockdown/overexpression, histone lactylation profiling, FASN ChIP, in vitro lactyltransferase assay, and DHA competition binding

   PMID:41803151

   Open questions at the time

   • Novel lactyltransferase activity not independently replicated
   • Catalytic mechanism and active-site basis for lactyltransfer not structurally defined
   • Reconciliation of an enzymatic activity with the chaperone/adaptor functions established earlier

• How NPM3's chaperone/adaptor roles relate to its reported lactyltransferase enzymatic activity, and whether these reflect one protein with multiple functions, remains unresolved.
• No structural model unifying the chaperone and enzymatic claims
• No independent confirmation of catalytic lactyltransferase activity